Collplant Biotechnologies Ltd (CLGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CLGN Annual Balance Sheets →
From Collplant Biotechnologies Ltd through Dec 31 2024, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent5.59
Restricted Investments, Current RE0.36
Cash & Short-term Investments5.00
Accounts receivable0.00
Inventories0.29
Prepaid Expense And Other Assets Current0.22
Total Current Assets6.75
Equipment/Property/Plant Net7.88
Intangible Assets0.07
Long-term investments0.08
Tax Assets, Noncurrent29.39
Intangible AssetsAnd Goodwill0.08
Total Assets10.79
Liabilities
Accounts Payable, Trade, Current0.61
Accrued Liabilities And Other Liabilities0.58
Total Current Liabilities2.67
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.56
Other liabilities, Noncurrent2.96
Total Liabilities4.70
Stockholders' Equity
Common Stock Value5.49
Additional Paid In Capital Common Stock126.40
Retained Earnings / Accumulated Deficit-124.84
Accumulated Other Comprehensive Income-0.97
Other Equity-0.97
Common Stockholder's Equity6.08
Total Stockholder's Equity6.08
Liabilities & Stockholder's Equity10.79
4 historic quarters locked

Sign in to unlock the full Collplant Biotechnologies Ltd balance sheet history.

About Collplant Biotechnologies Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-034393

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.